{{expand|time=2017-12-24T17:52:42+00:00}}
{{Drugbox
| drug_name = 非诺贝特<br>Fenofibrate
| verifiedrevid = 459443965
| IUPAC_name = propan-2-yl 2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoate
| image = fenofibrate structure.svg
| width = 182
<!--Clinical data-->
| tradename = 力平之、Fenoglide, Lipofen
| Drugs.com = {{drugs.com|monograph|fenofibrate}}
| MedlinePlus = a601052
| pregnancy_US = C
| legal_status = Legend 
| routes_of_administration = 口服
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 99%
| metabolism = [[葡萄糖醛酸|葡萄糖醛酸化]]
| elimination_half-life = 20 小时
| excretion = 尿液(60%), 粪便(25%)
<!--Identifiers-->
| IUPHAR_ligand = 7186
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 49562-28-9
| ATC_prefix = C10
| ATC_suffix = AB05
| ATC_supplemental =  
| PubChem = 3339
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01039
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3222
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U202363UOS
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00565
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 5001
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 672
<!--Chemical data-->
| C=20 | H=21 | Cl=1 | O=4
| molecular_weight = 360.831 g/mol
| smiles = O=C(c1ccc(Cl)cc1)c2ccc(OC(C(=O)OC(C)C)(C)C)cc2
| InChI = 1/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3
| InChIKey = YMTINGFKWWXKFG-UHFFFAOYAW
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YMTINGFKWWXKFG-UHFFFAOYSA-N
}}

'''非诺贝特（{{lang-en|Fenofibrate}}）'''，商品名如'''力平之'''，是一种[[贝特类|贝特类]][[药品|药物]]。非诺贝特主要用来降低有[[心血管疾病|心血管疾病]]风险的患者的[[胆固醇|胆固醇]]水平；与其他贝特类药物一样，非诺贝特降低[[低密度脂蛋白|低密度脂蛋白]]（LDL）和[[极低密度脂蛋白|极低密度脂蛋白]]（VLDL）水平，并且能升高[[高密度脂蛋白|高密度脂蛋白]]（HDL）水平和降低[[甘油三酯|甘油三酯]]（TG）水平。非诺贝特可以单独使用也可以与[[他汀类|他汀类]]药物联用来治疗[[高胆固醇血症|高胆固醇血症]]和[[高甘油三酯血症|高甘油三酯血症]]。<ref name="feno"/> 

非诺贝特自1975年起便开始使用，是最常用的贝特类药物之一，并且有着很好的效果和[[耐受性|耐受性]]。<ref name="feno">{{cite journal |vauthors=Yang LP, Keating GM |title=Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia |journal=Am J Cardiovasc Drugs |volume=9 |issue=6 |pages=401–9 |year=2009 |pmid=19929038 |doi=10.2165/11203920-000000000-00000}}</ref>

==引用==
{{reflist}}
{{血脂调节剂}}
[[Category:降血脂药|Category:降血脂药]]